Inbacef® Dry Syrup

Indication : Inbacef® is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below :
Uncomplicated urinary tract infections caused by Escherichia coli and Proteus mirabillis.
Otitis media caused by Haemophilus influenzae (β-lactamase positive and negative strains) , Moraxella (Branhamella) catarrhalis (most of which β-lactamase positive) and Streptococcus pyogenes.
Pharyngitis and tonsilitis caused by Streptococcus pyogenes.
Acute bronchitis and acute exacerbations of chronic bronchitis caused by Streptococcus pneumoniae and Haemophilus influenzae (β-lactamase positive and negative strains).

Composition : Each 5 ml (a measurement spoonful) Inbacef® Dry Syrup 100 mg/5 ml contains Cefixime trihydrate equicalent to Cefixime anhydrate 100 mg.

Presentation : Inbacef® Dry syrup 100 mg/5 ml
Box, 1 bottle @ 30 ml

On medical prescription only.

After reconstitution, the suspension may be kept for 7 days either at room temperature or under refrigeration, without significant loss of potency. Keep tightly closed. Discard unused portion after 7 days.